首页 | 本学科首页   官方微博 | 高级检索  
     


Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR
Authors:Charlotte J. Mitchell  Stuart P. Ballantine  Diane M. Coe  Caroline M. Cook  Christopher J. Delves  Mike D. Dowle  Chris D. Edlin  J. Nicole Hamblin  Stuart Holman  Martin R. Johnson  Paul S. Jones  Sue E. Keeling  Michael Kranz  Mika Lindvall  Fiona S. Lucas  Margarete Neu  Yemisi E. Solanke  Don O. Somers  Naimisha A. Trivedi  Joanne O. Wiseman
Affiliation:GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom
Abstract:Following the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective phosphodiesterase 4B inhibitors, [Hamblin, J. N.; Angell, T.; Ballentine, S., et al. Bioorg. Med. Chem. Lett. 2008, 18, 4237] the SAR of the 5-position was investigated further. A range of substituted heterocycles showed good potencies against PDE4. Optimisation using X-ray crystallography and computational modelling led to the discovery of 16, with sub-nM inhibition of LPS-induced TNF-α production from isolated human peripheral blood mononuclear cells.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号